Erratum: Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2–Associated Vestibular Schwannomas

J Jaishri O. Blakeley X Xiaobu Ye D Dan G. Duda (Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School) C Chris F. Halpin A Amanda L. Bergner A Alona Muzikansky V Vanessa L. Merker E Elizabeth R. Gerstner (Massachusetts General Hospital, Boston, MA) L Laura M. Fayad S Shivani Ahlawat M Michael A. Jacobs R Rakesh K. Jain C Christopher Zalewski E Eva Dombi B Brigitte C. Widemann S Scott R. Plotkin

Article Details

Volume / Issue Vol. 44, Issue 8
Published March 10, 2026
Pages 723-723
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (16)

J

Jaishri O. Blakeley

X

Xiaobu Ye

D

Dan G. Duda

Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School

C

Chris F. Halpin

A

Amanda L. Bergner

A

Alona Muzikansky

V

Vanessa L. Merker

E

Elizabeth R. Gerstner

Massachusetts General Hospital, Boston, MA

L

Laura M. Fayad

S

Shivani Ahlawat

M

Michael A. Jacobs

R

Rakesh K. Jain

C

Christopher Zalewski

E

Eva Dombi

B

Brigitte C. Widemann

S

Scott R. Plotkin